1. Glycyrrhizic acid: A promising carrier material for anticancer therapy
   Xitong Su et al, 2017, Biomedicine & Pharmacotherapy CrossRef
2. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
   Gretchen L. Bentz et al, 2019, PLOS ONE CrossRef
3. FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway
   Xiaorong Liu et al, 2019, BMC Cancer CrossRef